Gary D. Novack, Ph.D., Clinical Professor and Vice Chair for Collaborative Research in the Department of Ophthalmology & Vision Science, recently published his 400th paper.  Dr. Novack earned his Ph.D. in Pharmacology and Toxicology from UC Davis.  His early papers were in his original field of neuroscience, about treatment of epilepsy, and the neurophysiology of movement disorders such as Parkinsonism.  In his later papers, he wrote about novel therapeutic agents in the treatment of ophthalmic diseases, the process of drug development, as well as improved therapeutics.  His publications have been cited over 9000 times. Among his most cited papers are vitreous surgery for macular holes (with UCD Alumnus Robert Wendel MD), the Dry Eye Workshop, evaluation of how patients use eyedrops, and novel therapies for glaucoma, myopia, and uveitis.

Dr. Novack was a founding board member of The Ocular Surface, and serves on the editorial board for Journal of Ocular Pharmacology and Therapeutics and Eye and Contact Lens.  He is a diplomate of the American Board of Clinical Pharmacology, and a fellow of the American College of Clinical Pharmacology and the Association for Research in Vision and Ophthalmology (ARVO).  He was honored by ARVO with the Roger Vogel Award for Pharmaceutical Research, and by the American Academy of Ophthalmology twice for his service.  Dr. Novack is a Regent Emeritus of the University of California.  He has made major contributions to over 60 approved products.